The facility was inspected by the Ministry of Health of the Russian Federation from 17 February 2022 to 21 February 2022. The facility is involved in manufacturing, testing, packing, storage of chemically synthesized non-sterile drug substances for human use. Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets. Shilpa Medicares consolidated net profit surged 277% to Rs 29.55 crore on 63.7% increase in net sales to Rs 340.60 crore in Q4 FY22 over Q4 FY21. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
